She was mid-sentence in a presentation she had given a dozen times. She knew the word. It was right there. And then it wasn't. She paused, found a workaround, kept moving. Nobody in the room noticed.
She noticed. She drove home replaying it. She Googled "early dementia signs" before she got to the car.
She was 46. She was a senior executive. And she had never been afraid of her own brain before.
The first time I heard someone describe it this way — not as forgetfulness, but as fear — I understood something important about why brain fog is the most privately terrifying symptom of perimenopause.
We lose things. We lose keys and names and train of thought. And those losses are manageable, mostly. But when you lose a word mid-sentence, in public, in the middle of your own expertise — that is a different category of experience. That feels like something breaking.
I've spoken to enough women at this stage to know that the cognitive slip isn't what breaks them. It's the story they tell themselves about what it means. And the story they are telling — this is the beginning of the end, this is what I feared, this is my brain aging — is, for the overwhelming majority, simply not true.
So let's talk about what is actually happening. Because the mechanism is both more complex and more hopeful than the fear.
Brain fog in perimenopause is not vague.
It is a measurable neurological event with specific mechanisms — involving estradiol's role in brain plasticity, memory consolidation, and cerebral blood flow. And the most critical thing to understand is this: most of the cognitive changes that occur during the perimenopausal transition are transient and reversible.
This is not reassurance. It is neuroscience. And it changes what you do with the information.
Estradiol is a brain hormone — and its decline is measurable in your cognitive performance
Estradiol is not only a reproductive hormone. It is a potent neuroprotective agent. It supports the production of BDNF (brain-derived neurotrophic factor), the protein responsible for neuroplasticity — the brain's ability to form new connections, adapt, and learn. It also upregulates acetylcholine synthesis, a neurotransmitter critical for attention, learning, and memory formation. And it maintains cerebral blood flow — the delivery of oxygen and glucose to the neurons that need them.
As estradiol falls in perimenopause, all three of these functions decline measurably. The hippocampus — the brain region most responsible for forming and consolidating new memories — becomes temporarily less efficient. Specifically, working memory and word-finding are affected early. Long-term memory — the things you already know deeply — is largely preserved. This distinction is critical: the experiences most women report (losing the word, forgetting where they put something, losing a train of thought mid-sentence) are working memory functions, not long-term memory decline.
You are not losing what you know. You are having difficulty holding new information in real time. That is a different problem — and a more solvable one.
The hippocampus during perimenopause: temporarily less efficient, not damaged
The CAN-PROTECT study and other longitudinal research have found that specific cognitive domains — processing speed, verbal fluency, and working memory — show measurable changes during the perimenopause transition, correlating with estradiol fluctuation. The pattern is not linear decline. It is transition-associated disruption, much of which stabilises post-menopause.
The hippocampus has high concentrations of estrogen receptors. When estradiol fluctuates — and in perimenopause, it fluctuates dramatically before it declines — the hippocampus experiences corresponding instability. This is what produces the feeling of cognitive unreliability: not a steady decline, but a pattern of unpredictable performance that feels more distressing precisely because it is inconsistent.
On high-estradiol days, the brain feels clear. On low-estradiol days, it doesn't. This variability is not imagination. It is the hormone doing exactly what it does to the hippocampus.
The reversibility question — and what the evidence actually says
The critical window hypothesis suggests that estradiol's neuroprotective effects — particularly on amyloid clearance and hippocampal function — are strongest when interventions are initiated during the transition, not after. Research presented at the 2025 Annual Meeting of The Menopause Society reinforced that earlier menopause is associated with greater brain health vulnerability, underscoring that the perimenopausal window is when action matters most.
For most women, targeted interventions during this period — whether hormonal, lifestyle-based, or both — produce meaningful cognitive recovery. Aerobic exercise elevates BDNF directly. Deep sleep drives glymphatic clearance of amyloid. Omega-3s reduce neuroinflammation. Hormonal stabilisation, when appropriate, restores the estradiol floor that cognitive function depends on.
This is not about preventing aging. It is about navigating a specific transition with the right support at the right time.
This is not dementia — and it needs to be said out loud
Dementia involves progressive, irreversible loss across multiple cognitive domains. Perimenopausal brain fog involves transition-associated fluctuation in specific working memory functions, with a clear hormonal driver and documented reversibility in most cases.
These are not the same thing. Treating them as the same — in your own mind, or in the absence of proper clinical evaluation — produces fear that leads to inaction, when this is precisely the moment for action.
If cognitive changes are significant, sudden, involve personality changes, or affect multiple domains simultaneously, those warrant clinical evaluation. Perimenopausal brain fog does not mean dementia is coming. It means estradiol is transitioning — and so is your brain.
That executive found her way to a menopause specialist, had her hormonal picture assessed, and understood — for the first time — that the word she'd lost mid-sentence was not an omen. It was data.
She made changes. The fog lifted. She still occasionally loses a word. She no longer drives home terrified about it.
"I stopped treating every slip like evidence," she told me. "Once I understood the mechanism, it became information instead of a verdict."
Brain fog is not a character flaw. It is not early dementia. It is estradiol in transition — and the vast majority of what you are experiencing is both explainable and reversible with the right support.
The most valuable thing you can do this week: tell your clinician specifically which cognitive domains are affected. Not "I feel foggy" — but "my word retrieval is slower, my working memory under stress has changed, my processing speed on complex tasks has shifted." That level of specificity directs the clinical conversation.
At EmpressHealth.ai, our cognitive health module maps your specific pattern against the hormonal picture — because "brain fog" is not a symptom. It is a collection of mechanisms that deserve individual attention.
Your brain is not failing you. It is transitioning. There is a difference — and it matters enormously.